Polymeric micelles, ie aggregation colloids formed in solution by self-assembling of
amphiphilic polymers, represent an innovative tool to overcome several issues related to …

Lipid nanoparticles, especially liposomes and lipid/nucleic acid complexed nanoparticles
have shown great success in the pharmaceutical industry. Their success is attributed to …

Nowadays, medicinal herbs and their phytochemicals have emerged as a great therapeutic
option for many disorders. However, poor bioavailability and selectivity might limit their …

Lipid vesicles can provide a cost-effective enhancement of skin drug absorption when
vesicle production process is optimised. It is an important challenge to design the ideal …

It has been known that a considerable number of drugs in clinical use or under development
are water-insoluble drugs with poor bioavailability (BA). The liposomal delivery system has …

The aim of this work was to clarify the dynamics behind the influence of ionic strength on the
changes in drug release from large unilamellar vesicles (LUVs). For this purpose, we have …

In the last decades, pharmaceutical interested researches aimed to develop novel and
innovative drug delivery techniques in the medical and pharmaceutical fields. Recently …

Lipid polymer hybrid nanoparticles (LPHN) are novel systems which are potentially
emerging in the era of nano-medicine. They are core-shell nanostructures which comprise of …

Dialysis methods are frequently used to determine the in vitro drug release kinetics of
nanoparticle drug delivery systems. However, the need for the released drug to diffuse …

Anticoagulants prevent the blood from developing the coagulation process, which is the
primary cause of death in thromboembolic illnesses. Phenindione (PID) is a well-known …